HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz. , July 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper (the “White Paper”), further establishing the